Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Astellas Overactive Bladder Drug Raises Risks, FDA Staff Says
Astellas Overactive Bladder Drug Raises Risks, FDA Staff Says
Astellas Overactive Bladder Drug Raises Risks, FDA Staff Says
Submitted by
admin
on April 3, 2012 - 8:54am
Source:
Bloomberg
News Tags:
Astellas
overactive bladder
FDA
mirabegron
Headline:
Astellas Overactive Bladder Drug Raises Risks, FDA Staff Says
Do Not Allow Advertisers to Use My Personal information
